Wellness That Matters: Black Health News & Community Care
- U.S. News list topped by the University of Texas MD Anderson Cancer Center in Houston.
- FDA advisory committee will review the Galleri multi-cancer early detection (MCED) test next month.
- FDA approved expanded indication for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) with AR pathway inhibitors for PSMA-positive metastatic hormone-sensitive prostate cancer.
Former First Lady Jill Biden said she noticed a concerning symptom before former President Joe Biden was diagnosed with aggressive prostate cancer — he was waking up to use the bathroom up to seven times a night. (USA Today)
Sydney Towle, an influencer who documented her life with the rare bile duct cancer cholangiocarcinoma on TikTok, died from the disease at the age of 26. (People)
U.S. News & World Report released its list of the country’s best cancer hospitals, which was headed by the University of Texas MD Anderson Cancer Center in Houston.
Jazz Pharmaceuticals said it plans to ask the FDA to remove a second-line small cell lung cancer indication from the label for lurbinectedin (Zepzelca) after the drug failed to improve overall survival in the confirmatory phase III LAGOON trial. (Fierce Pharma)
Liquid biopsy was able to predict within weeks whether patients with advanced non-small cell lung cancer were benefitting from immunotherapy, according to a clinical validity study. (Johns Hopkins Medicine)
Digital patient-reported outcome monitoring reduced fatigue and improved physical function in patients with metastatic breast cancer, a randomized trial showed. (JAMA Oncology)
The FDA approved an expanded indication for lutetium Lu 177 vipivotide tetraxetan (Pluvicto) in combination with androgen receptor pathway inhibitor therapy to include prostate-specific membrane antigen (PSMA)-positive metastatic hormone-sensitive prostate cancer.
An FDA advisory committee will review the Galleri multi-cancer early detection (MCED) test next month, Grail announced.
A study of childhood cancer survivors showed that the heart-protective drug dexrazoxane reduced heart damage caused by chemotherapy 15 years or more after the end of treatment. (University of Florida)
A cost-effective, scalable education program targeting hematopoietic cell transplant survivors can improve screening for skin cancer and reduce skin cancer risk. (City of Hope)
Response rate has become the most common surrogate endpoint, surpassing even progression-free survival, for cancer drug approvals for solid tumors. (JAMA)
Adding high-dose vitamin D3 to standard treatment failed to improve progression-free survival in patients with metastatic colorectal cancer in the SOLARIS randomized trial. (JAMA)
Bruce Springsteen said his wife, Patti Scialfa, is in remission from multiple myeloma. (USA Today)
Read the full article on the original site
